HealthReport Predicts 1 in 5 Individuals in England to Confront Major Illness...

Report Predicts 1 in 5 Individuals in England to Confront Major Illness by 2040

In a recent publication by The Health Foundation, it is projected that approximately 9.1 million individuals in England will grapple with significant illnesses by the year 2040, signifying a substantial 37% surge equating to 2.5 million more people compared to the statistics of 2019.

This projection signals a transition from nearly one in six of the adult population living with major ailments in 2019 to an estimated one in five individuals by 2040.

Analysing a range of health conditions, the report discloses that 19 out of 20 studied conditions are anticipated to rise in prevalence, encompassing an increase of over 30% in the numbers of those living with conditions such as cancer, diabetes, and kidney disease.

Remarkably, it is predicted that 80% of the anticipated growth in major illness cases (amounting to 2 million individuals) will be concentrated among those aged 70 and above, while the remaining 20% (equating to 500,000 individuals) will pertain to the working-age population aged between 20 to 69 years old.

The task of curbing the escalation in major illness cases is multifaceted and lacks a single solution. The complexities of enhancing care for an ageing population and extending independent living are not exclusive to England.

Amidst an aging demographic, decreasing birth rates, financial constraints in government funding, the impact of climate change, and the challenges of sustaining an affordable standard of living, countries worldwide are encountering similar pressures upon their healthcare systems.

Fortunately for the residents of the UK, the protection insurance industry presents a glimmer of hope. While products like Critical Illness Cover and Income Protection Insurance may not offer remedies or prevention for severe illnesses, the tax-free disbursements provided during these trying times can significantly alleviate the financial burden on affected individuals.

Heidi Loughlin, a mother of two sons hailing from Bristol, has been bravely facing stage 4 inflammatory breast cancer since 2015. In conversation with Protect Line, a prominent UK protection insurance brokerage, she asserts, “In this contemporary era, we are living remarkably well despite enduring incurable illnesses – it is imperative to contemplate the potential longevity of one’s life, which might span a considerable duration.”

“Amidst undergoing chemotherapy, radiotherapy, surgical procedures, and hormone treatments, the aspect of my financial stability remains a concern. I wholeheartedly implore anyone, regardless of whether they have dependents or not, to secure appropriate insurance coverage,” Loughlin fervently appeals.

News Desk
News Deskhttps://www.businessmanchester.co.uk/
The Business Manchester News Desk team is a collective of experienced journalists and editors dedicated to delivering comprehensive business news and insights from the Manchester area and beyond. With a strong background in finance, technology, property, and innovation, our team ensures that our readers stay well-informed about the latest trends and developments in the business world. Through in-depth reports and insightful analysis, the Business Manchester News Desk team is committed to providing high-quality journalism to its audience.
Latest

Modest rise in household bills expected, but global uncertainty may drive further increases

Household expenses are forecast to increase by around £80 annually from April, considerably less than the £660 rise seen by many consumers last year....

Manchester launches bold five-year City of Cycling plan

Manchester City Council, in partnership with Manchester Active, Transport for Greater Manchester (TfGM), British Cycling, Cycling UK and Marketing Manchester, has launched the Manchester...

Why more Manchester businesses are turning to self storage to cut overheads

Commercial property costs in Manchester have risen steadily over the past decade. For SMEs navigating post-pandemic hybrid working, shifting consumer demand, and tighter margins,...

CLEAN Services Introduces Pisys Permit to Work Platform Across UK Sites

CLEAN Services has rolled out the Pisys Permit to Work system throughout its operations in the United Kingdom, replacing its previous paper-based method and...
Subscribe to our newsletter
Business Manchester will use the information you provide on this form to be in touch with you and to provide updates and marketing.
Don't miss

CLEAN Services Introduces Pisys Permit to Work Platform Across UK Sites

CLEAN Services has rolled out the Pisys Permit to Work system throughout its operations in the United Kingdom, replacing its previous paper-based method and...

Manchester launches bold five-year City of Cycling plan

Manchester City Council, in partnership with Manchester Active, Transport for Greater Manchester (TfGM), British Cycling, Cycling UK and Marketing Manchester, has launched the Manchester...

Modest rise in household bills expected, but global uncertainty may drive further increases

Household expenses are forecast to increase by around £80 annually from April, considerably less than the £660 rise seen by many consumers last year....

Debt is hitting mental health and relationships harder, new research finds

New data from Money Wellness shows that financial pressure in the UK is becoming more focused and more damaging in specific areas of people's...

More News

3 Scientifically-backed benefits of whole-body cryotherapy

The popularity of whole-body cryotherapy has surged in recent years. What was once a niche recovery tool reserved for elite athletes is now accessible...

Algeos introduces Interpod Orthotic Library for clinicians across the UK

Orthotics supplier Algeos has announced the UK release of the new Interpod Orthotic Library, a clinically organised reference designed to assist healthcare professionals in...

IBSA UK introduces Hyaluxelle®, a non-hormonal injectable for menopausal vulvovaginal symptoms

An advanced hyaluronic acid-based treatment developed to address the sexual and genital symptoms associated with GSM. IBSA UK, the UK arm of Swiss pharmaceutical company...